FDA Issues Equine Anthelmintic Guidance to Support International Veterinary Drug Reviews
June 27, 2026
June 27, 2026
WASHINGTON, June 27 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has issued final guidance outlining recommendations for equine anthelmintic studies supporting international veterinary drug approvals worldwide.
The guidance, announced in a notice published in the Federal Register, is Guidance for Industry (GFI) No. 109, Effectiveness of Anthelmintics: Specific Recommendations for Equines. It was developed through the International Cooperat . . .
The guidance, announced in a notice published in the Federal Register, is Guidance for Industry (GFI) No. 109, Effectiveness of Anthelmintics: Specific Recommendations for Equines. It was developed through the International Cooperat . . .